Q97975870

Summary

Q97975870 is a motion^[1].

Key Facts

• Q97975870 authored Ulla Orring^[2].
• Q97975870 authored Barbro Westerholm^[3].
• Q97975870's instance of is recorded as motion^[4].
• Q97975870's part of the series is recorded as motions of the 1991-1992 legislative session of the Riksdag^[5].
• Q97975870's language of work or name is recorded as Swedish^[6].
• Q97975870 was released on +1992-04-10T00:00:00Z^[7].
• Q97975870's main subject is medication^[8].
• Q97975870's work available at URL is recorded as http://data.riksdagen.se/dokument/GF02So25^[9].
• Q97975870's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GF02So25^[10].
• Q97975870's applies to jurisdiction is recorded as Sweden^[11].
• Q97975870's legal citation of this text is recorded as Mot. 1991/92:So25^[12].
• Q97975870's title is recorded as med anledning av prop. 1991/92:107 Ny läkemedelslag m.m.^[13].
• Q97975870's has immediate cause is recorded as Q98143494^[14].
• Q97975870's cites work is recorded as Q98143494^[15].
• Q97975870's maintained by WikiProject is recorded as Project Riksdagen's documents^[16].
• Q97975870's copyright status is recorded as public domain^[17].
• Q97975870's legislative committee is recorded as Committee on Health and Welfare^[18].

Body

Definition and Type

Q97975870's instance of is recorded as motion^[4].